Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: A causal or casual relationship?
- 1 July 2003
- Vol. 134 (1) , 41-44
- https://doi.org/10.1067/msy.2003.158
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidismKidney International, 2000
- Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenomaKidney International, 1999
- Parathyroid Hyperplasia, Adenomas, and CarcinomasThe American Journal of Surgical Pathology, 1999
- Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidismSurgery, 1997
- Sestamibi parathyroid imagingSeminars in Nuclear Medicine, 1995
- Thyroid and parathyroid imagingSeminars in Nuclear Medicine, 1994
- Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retentionEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Physiological basis of myocardial perfusion imaging with the technetium 99m agentsSeminars in Nuclear Medicine, 1991
- Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism: Consensus Development Conference StatementAnnals of Internal Medicine, 1991
- Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.Circulation, 1990